Sponsor
1 L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis Mayo Clinic Proceedings, April 19, 2013 Evidence Based Medicine Review Article
2 Sudden Cardiac Death in Hypertrophic Cardiomyopathy Circulation: Arrhythmia and Electrophysiology, April 18, 2013
3 Atrial fibrillation-induced cardiac troponin I release International Journal of Cardiology, April 29, 2013
4 Atrial Fibrillation in Athletes International Journal of Sports Medicine, May 3, 2013
5 Atrial Fibrillation and Atrial Flutter in HIV-Infected Persons: Incidence, Risk Factors, and Association with Markers of HIV Disease Severity JACC - Journal of the American College of Cardiology, April 17, 2013
6 New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: More Choices Bring More Challenges Hospital Pharmacy, May 8, 2013 Review Article
7 Stroke and ventricular arrhythmias International Journal of Cardiology, April 25, 2013 Evidence Based Medicine Review Article
8 Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study European Journal of Heart Failure, May 6, 2013
9 Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial European Heart Journal, April 19, 2013
10 Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock Delivery: The ADVANCE III Randomized Clinical Trial JAMA, May 8, 2013 Evidence Based Medicine
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor